Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus

被引：0
作者：
Adha, Syah Akbarul [1 ]
Afifah, Nadiya Nurul [1 ,2 ]
Latarissa, Irma Rahayu [3 ,4 ]
Iftinan, Ghina Nadhifah [4 ]
Kusuma, Arif Satria Wira [1 ,2 ]
Febriyanti, Raden Maya [1 ]
Barliana, Melisa Intan [1 ,2 ]
Lestari, Keri [2 ,3 ,4 ]
机构：
[1] Univ Padjadjaran, Fac Pharm, Dept Biol Pharm, Sumedang, Indonesia
[2] Univ Padjadjaran, Ctr Excellence Pharmaceut Care Innovat, Sumedang, Indonesia
[3] Univ Padjadjaran, Fac Pharm, Dept Pharmacol & Clin Pharm, Jl Raya Bandung Sumedang Km 21, Sumedang 45363, Indonesia
[4] Univ Padjadjaran, Medicat Therapy Adherence Clin MTAC, Sumedang, Indonesia
来源：
DIABETES METABOLIC SYNDROME AND OBESITY | 2025年 / 18卷
关键词：
COVID-19; diabetes mellitus; antidiabetic; immunomodulator; anti-inflammatory; herbal medicines; CLINICAL CHARACTERISTICS; ANDROGRAPHIS-PANICULATA; SARS CORONAVIRUS; QUININE SULFATE; BLOOD-GLUCOSE; SARS-COV-2; MORTALITY; INFECTION; INSULIN; EFFICACY;
D O I：
10.2147/DMSO.S498774
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Diabetes mellitus (DM) is recognized and classified as a group of conditions marked by persistent high blood glucose levels. It is also an inflammatory condition that may influence concurrent disease states, including Coronavirus Disease 2019 (COVID19). Currently, no effective drug has been found to treat COVID-19, especially in DM patients. Many herbal medicines, such as the well-known Andrographis paniculata, have been explored as drugs and complementary therapies due to their antidiabetic, antibacterial, antiviral, anti-inflammatory, and immunomodulatory effects. This study aimed to examine the potential of herbal medicines as complementary therapy in DM patients with COVID-19 complications, drawing from in-vitro and in-vivo investigations. This study analyzed articles published within the last 15 years using keywords including "herbal medicines", "COVID-19", "Diabetes Mellitus", "antidiabetics", "antiviral", and "anti-inflammatory". The results showed that several herbal medicines could serve as complementary therapy for DM patients with COVID-19 complications. These include Andrographis paniculata, Ageratum conyzoides, Artocarpus altilis, Centella asiatica, Momordica charantia, Persea gratissima, Phyllanthus urinaria, Physalis angulata, Tinospora cordifolia, and Zingiber zerumbet. Herbal medicines may serve as a complementary therapy for DM patients with COVID-19, but these claims need experimental validation in infection models and among affected patients.
引用
收藏
页码：135 / 146
页数：12
相关论文
共 100 条
  • [1] jin ZJ, Dong X, yuan CY, Et al., Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy: European Journal of Allergy and Clinical Immunology, 75, 7, (2020)
  • [2] Di Gennaro F, Pizzol D, Marotta C, Et al., Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review, Int J Environ Res Public Health, 17, 8, (2020)
  • [3] Ajebli M, Amssayef A, Akdad M, Et al., Chronic diseases and COVID-19: a review, Endocr Metab Immune Disord Drug Targets, 21, 10, pp. 1781-1803, (2021)
  • [4] Zhao Z, Li L, Sang Y., The COVID-19 pandemic increased poor lifestyles and worsen mental health: a systematic review, Am J Transl Res, 15, pp. 3060-3066, (2023)
  • [5] Lim S, Kong APS, Tuomilehto J., Influence of COVID-19 pandemic and related quarantine procedures on metabolic risk, Prim Care Diabetes, 15, 5, pp. 745-750, (2021)
  • [6] Zimmet P, Alberti KG, Magliano DJ, Bennett PH., Diabetes mellitus statistics on prevalence and mortality: facts and fallacies, Nat Rev Endocrinol, 12, 10, pp. 616-622, (2016)
  • [7] Bornstein SR, Rubino F, Khunti K, Et al., Practical recommendations for the management of diabetes in patients withCOVID-19, Lancet Diabetes Endocrinol, 8, 6, pp. 546-550, (2020)
  • [8] Letko M, Marzi A, Munster V., Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses, Nat Microbiol, 5, pp. 562-569, (2020)
  • [9] Latarissa IR, Barliana MI, Meiliana A, Lestari K., Potential of quinine sulfate for COVID-19 treatment and its safety profile: review, Clin Pharmacol, 13, pp. 225-234, (2021)
  • [10] Li W, Moore MJ, Vasilieva N, Et al., Angiotensin-converting enzyme 2 is a functional receptor for the SARScoronavirus, Nature, 426, 6965, pp. 450-454, (2003)
12345678910